Skip to main content
Show — Main navigation
Hide — Main navigation
Submit an Article
Transurethral Ultrasound Ablation (TULSA) for Prostate Cancer Treatment: An Interview With Joseph J. Busch, Jr., MD
April 18, 2020
Dr Busch spoke with IO Learning about integrating the recently FDA-approved TULSA treatment into his practice.
Current Therapies and Future Options for Breast Cancer Treatment: An Interview With Yolanda Bryce, MD
March 25, 2020
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.
Tumor-Targeted Dyes for Fluorescence-Guided Cancer Treatment: An Interview With Philip Low, MD
March 09, 2020
Dr Philip Low of On Target Laboratories discusses OTL38, a novel, tumor-targeted dye used to guide cancer surgery.
Primer on Nerve Anatomy to Avoid Complications: An Interview With Matthew Callstrom, MD, PhD
March 06, 2020
Dr Matthew Callstrom shares his thoughts about the importance of learning nerve anatomy to avoid complications during ablation procedures.
Hepatic Embolotherapies for Metastatic Neuroendocrine Tumors: An Interview With Jonathan Strosberg, MD
February 10, 2020
Dr Strosberg spoke with IO Learning at CIO 2019 about his experience with various embolization techniques and the latest data on these treatment modalities.
Radiation Segmentectomy and Radiation Lobectomy: An Interview With Siddharth Padia, MD
February 04, 2020
Dr Padia spoke with IO Learning about his findings on making unresectable patients resectable, success in using a newer technique, and the future of tumor ablation.
The Role of IO in a Cancer Center: An Interview With Michael Zinner, MD
January 30, 2020
Dr Zinner is the CEO and Executive Medical Director at Miami Cancer Institute. He spoke with IO Learning about the role of interventional oncology at the Miami Cancer Institute.
Tips on Treating Patients in an Outpatient Setting: An Interview With Edgar St. Amour, MD
January 21, 2020
Dr St. Amour shares his unique perspective on transitioning from a hospital setting to treating patients in an outpatient setting.
Nerve Blocks and Neurolysis: An Interview With David Prologo, MD
October 13, 2019
David Prologo, MD, presented on cryoneurolysis at the Symposium on Clinical Interventional Oncology (CIO) in Miami, Florida. Dr. Prologo is an interventional radiologist from Emory University in Atlanta, Georgia, and his presentation identified…
Renal Mass Biopsy: When Is it Justified and What do the Guidelines Say?
October 03, 2019
Tim McClure, MD, discussed biopsy and ablation staging, circumstances in which renal mass biopsy is necessary, and recommendations from guidelines.
Bland Embolization: Why and How?
October 02, 2019
Karen Brown, MD, FSIR, presented on the rationale for embolization with particles/microspheres alone, and how survival and complication outcomes for patients are the same as with other therapies.
Back to Top